Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

BACKGROUND: There has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continued comprehensive and equitable healthcare. There is though confusion surro...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamski, Jakub, Godman, Brian, Ofierska-Sujkowska, Gabriella, Osińska, Bogusława, Herholz, Harald, Wendykowska, Kamila, Laius, Ott, Jan, Saira, Sermet, Catherine, Zara, Corrine, Kalaba, Marija, Gustafsson, Roland, Garuolienè, Kristina, Haycox, Alan, Garattini, Silvio, Gustafsson, Lars L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906457/
https://www.ncbi.nlm.nih.gov/pubmed/20529296
http://dx.doi.org/10.1186/1472-6963-10-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906457/
https://www.ncbi.nlm.nih.gov/pubmed/20529296
http://dx.doi.org/10.1186/1472-6963-10-153

Ejemplares similares